LongCOVID-Fighters: A randomized controlled trial for treating Post-COVID symptoms of adolescents and young adults

LongCOVID-Fighters: A randomized controlled trial for treating Post-COVID symptoms of adolescents and young adults - LongCOVID Fighters

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00027968

Enrollment

Registered

2022-04-21

Start date

2022-05-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U09.9 F43

Interventions

Group 1: Intervention: Neuropsychological Training with training for relaxation and breathe Group 2: Waitinglist

Eligibility

Sex/Gender

All

Age

12 Years to 21 Years

Inclusion criteria

Inclusion criteria: Patients have a history of surviving and proven COVID-19 infection (=12 months; U07.1), can take part in outpatient therapy, age 14-21 years

Exclusion criteria

Exclusion criteria: Medication or drug abuse

Design outcomes

Primary

Measure	Time frame
T1, T2, T3: Fatigue (Questionnaire), Selective Attention/Vigilance (Computertest), Cortisol secretion (Hair cortisol)	—

Secondary

Measure	Time frame
T1, T2, T3: Memory (Computertest), Quality of Life, Anxiety, Depression, PTSD caused by Post-Covid-Symptoms (Questionnaire/Interview)	—

Countries

Austria

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026